0000000000718502

AUTHOR

Massimo Imbriaco

showing 3 related works from this author

Effects of Interobserver Variability on 2D and 3D CT- and MRI-Based Texture Feature Reproducibility of Cartilaginous Bone Tumors

2021

AbstractThis study aims to investigate the influence of interobserver manual segmentation variability on the reproducibility of 2D and 3D unenhanced computed tomography (CT)- and magnetic resonance imaging (MRI)-based texture analysis. Thirty patients with cartilaginous bone tumors (10 enchondromas, 10 atypical cartilaginous tumors, 10 chondrosarcomas) were retrospectively included. Three radiologists independently performed manual contour-focused segmentation on unenhanced CT and T1-weighted and T2-weighted MRI by drawing both a 2D region of interest (ROI) on the slice showing the largest tumor area and a 3D ROI including the whole tumor volume. Additionally, a marginal erosion was applied…

Artificial intelligenceFuture studiesIntraclass correlationChondrosarcomaBone NeoplasmsArticleRegion of interestNeoplasmsArtificial intelligence Chondroma Chondrosarcoma Neoplasms Radiomics Texture analysisHumansMedicineRadiology Nuclear Medicine and imagingSegmentationTexture featureRetrospective StudiesObserver VariationReproducibilityRadiomicsRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryReproducibility of ResultsMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingComputer Science ApplicationsTexture analysisFeature (computer vision)ChondrosarcomaTomography X-Ray ComputedbusinessNuclear medicineChondromaChondromaJournal of Digital Imaging
researchProduct

Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.

2017

PURPOSE: Multiple sclerosis (MS) has been proposed as a possible differential diagnosis for Fabry disease (FD). The aim of this work was to evaluate the involvement of corpus callosum (CC) on MR images and its possible role as a radiological sign to differentiate between FD and MS. METHODS: In this multicentric study, we retrospectively evaluated the presence of white matter lesions (WMLs) on the FLAIR images of 104 patients with FD and 117 patients with MS. The incidence of CC-WML was assessed in the two groups and also in a subgroup of 37 FD patients showing neurological symptoms. RESULTS: WMLs were detected in 50 of 104 FD patients (48.1%) and in all MS patients. However, a lesion in the…

AdultMalemedicine.medical_specialtyPathologyNeurologySettore MED/09 - Medicina InternaAdolescentCorpus callosumFluid-attenuated inversion recoveryCorpus callosumCorpus callosum; Fabry disease; MRI; Multiple sclerosis030218 nuclear medicine & medical imagingDiagnosis DifferentialMultiple sclerosis03 medical and health sciences0302 clinical medicinemedicineHumansRadiology Nuclear Medicine and imagingAgedRetrospective StudiesNeuroradiologyFabry diseasebusiness.industryMultiple sclerosisMiddle Agedmedicine.diseaseMagnetic Resonance ImagingFabry diseaseHyperintensityCorpus callosum; Fabry disease; MRI; Multiple sclerosis.FemaleNeurology (clinical)RadiologyDifferential diagnosisCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryMRI
researchProduct

A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report

2012

Abstract Background Fabry disease (FD) is a hereditary metabolic disorder caused by the partial or total inactivation of a lysosomal hydrolase, the enzyme α-galactosidase A (GLA). This inactivation is responsible for the storage of undegraded glycosphingolipids in the lysosomes with subsequent cellular and microvascular dysfunction. The incidence of disease is estimated at 1:40,000 in the general population, although neonatal screening initiatives have found an unexpectedly high prevalence of genetic alterations, up to 1:3,100, in newborns in Italy, and have identified a surprisingly high frequency of newborn males with genetic alterations (about 1:1,500) in Taiwan. Case presentation We des…

lcsh:Diseases of the circulatory (Cardiovascular) systemPathologyα-galactosidase AAnderson-Fabry mutationBiopsyDNA Mutational AnalysisCase Reportmedicine.disease_causeGlobotriaosylceramide0302 clinical medicineSettore BIO/13 - Biologia ApplicataPromoter Regions Genetic0303 health sciencesMutationeducation.field_of_studymedicine.diagnostic_testbiologyMetabolic disorderMagnetic Resonance Imaging3. Good healthPhenotypeCardiovascular DiseasesDisease ProgressionFemaleKidney DiseasesRenal biopsyCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyPopulation03 medical and health sciencesPredictive Value of TestsBiopsymedicineHumansHigh resolution meltingGenetic Predisposition to Diseaseeducation030304 developmental biologyFabry diseaseAlpha-galactosidasebusiness.industrymedicine.diseaseFabry diseaseIntronslcsh:RC666-701alpha-GalactosidaseMutationGLAbiology.proteinbusiness030217 neurology & neurosurgeryKidney disease
researchProduct